Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device heartmate II

Circulation: Heart Failure

Volumn 6, Issue 3, 2013, Pages 517-526

  Wever Pinzon, Omar ^a,b,c   Selzman, Craig H ^a,b,c   Drakos, Stavros G ^a,b,d   Saidi, Abdulfattah ^a,b,c,d   Stoddard, Gregory J ^b   Gilbert, Edward M ^a,b,c   Labedi, Mohamed ^a,b,c,d   Reid, Bruce B ^a,d   Davis, Erin S ^a,b,c   Kfoury, Abdallah G ^a,d   Li, Dean Y ^b,c,e   Stehlik, Josef ^a,b,c   Bader, Feras ^a,b,c  

^a Utah Transplantation Affiliated Hospitals UTAH   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d INTERMOUNTAIN MEDICAL CENTER   (United States)

^e SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Aortic valve opening; Bleeding; Heartmate ii; Left ventricular assist device; Pulsatility

Indexed keywords

ALANINE AMINOTRANSFERASE; HEMOGLOBIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AORTA VALVE; ARTICLE; BLEEDING; BLOOD FLOW VELOCITY; BRAIN HEMORRHAGE; CARDIOVASCULAR PARAMETERS; CHRONIC KIDNEY DISEASE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED STUDY; EPISTAXIS; ERYTHROCYTE TRANSFUSION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART TRANSPLANTATION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HEMOSTASIS; HUMAN; INTRACARDIAC ECHOCARDIOGRAPHY; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULSATILE FLOW; PULSATILITY INDEX; THROMBOCYTE COUNT; URINARY TRACT HEMORRHAGE;

AORTIC VALVE OPENING; BLEEDING; HEARTMATE II; LEFT VENTRICULAR ASSIST DEVICE; PULSATILITY;

AGED; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULSATILE FLOW; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84879239446     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.112.000206     Document Type: Article

References (42)

1. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Baldwin JT, Young JB. The Fourth INTERMACS Annual Report: 4000 implants and counting. J Heart Lung Transplant. 2012;31:117-126.
2. Bader FM, Islam N, Mehta NA, Worthen N, Ishihara S, Stehlik J, Gilbert EM, Litwin SE. Noninvasive diagnosis of cardiac allograft rejection using echocardiography indices of systolic and diastolic function. Transplant Proc. 2011;43:3877-3881.
3. Frazier OH, Rose EA, McCarthy P, Burton NA, Tector A, Levin H, Kayne HL, Poirier VL, Dasse KA. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg. 1995;222:327-336; discussion 336.
4. Frazier OH, Rose EA, Oz MC, Dembitsky W, McCarthy P, Radovancevic B, Poirier VL, Dasse KA; HeartMate LVAS Investigators. Left ventricular assist system. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg. 2001;122:1186-1195.
5. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
6. Frazier OH, Myers TJ, Westaby S, Gregoric ID. Use of the jarvik 2000 left ventricular assist system as a bridge to heart transplantation or as destination therapy for patients with chronic heart failure. Ann Surg. 2003;237:631-636; discussion 636-637.
7. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, Conte JV, Naka Y, Mancini D, Delgado RM, MacGillivray TE, Farrar DJ, Frazier OH; HeartMate II Clinical Investigators. Use of a continuousflow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885-896.
8. Strueber M, O'Driscoll G, Jansz P, Khaghani A, Levy WC, Wieselthaler GM; HeartWare Investigators. Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol. 2011;57:1375-1382.
9. Haj-Yahia S, Birks EJ, Rogers P, Bowles C, Hipkins M, George R, Amrani M, Petrou M, Pepper J, Dreyfus G, Khaghani A. Midterm experience with the Jarvik 2000 axial flow left ventricular assist device. J Thorac Cardiovasc Surg. 2007;134:199-203.
10. Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, Russell SD, Conte JV, Aaronson KD, McGee EC Jr, Cotts WG, DeNofrio D, Pham DT, Farrar DJ, Pagani FD. Results of the post-US Food and Drug Administration- approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol. 2011;57:1890-1898.
11. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Ulisney KL, Baldwin JT, Young JB. Second INTERMACS annual report: more than 1000 primary left ventricular assist device implants. J Heart Lung Transplant. 2010;29:1-10.
12. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Ulisney KL, Baldwin JT, Young JB. Third INTERMACS Annual Report: the evolution of destination therapy in the United States. J Heart Lung Transplant. 2011;30:115-123.
13. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg. 2008;86:1227-1234; discussion 1234.
14. Crow S, Chen D, Milano C, Thomas W, Joyce L, Piacentino V 3rd, Sharma R, Wu J, Arepally G, Bowles D, Rogers J, Villamizar-Ortiz N. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg. 2010;90:1263-1269; discussion 1269.
15. Klovaite J, Gustafsson F, Mortensen SA, Sander K, Nielsen LB. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol. 2009;53:2162-2167.
16. Uriel N, Pak SW, Jorde UP, Jude B, Susen S, Vincentelli A, Ennezat PV, Cappleman S, Naka Y, Mancini D. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010;56:1207-1213.
17. Meyer AL, Malehsa D, Bara C, Budde U, Slaughter MS, Haverich A, Strueber M. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail. 2010;3:675-681.
18. Letsou GV, Shah N, Gregoric ID, Myers TJ, Delgado R, Frazier OH. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant. 2005;24:105-109.
19. Demirozu ZT, Radovancevic R, Hochman LF, Gregoric ID, Letsou GV, Kar B, Bogaev RC, Frazier OH. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2011;30:849-853.
20. Heyde EC. Gastrointestinal bleeding in aortic stenosis. N Engl J Med. 1958;259:196.
21. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
22. Cowger J, Pagani FD, Haft JW, Romano MA, Aaronson KD, Kolias TJ. The development of aortic insufficiency in left ventricular assist devicesupported patients. Circ Heart Fail. 2010;3:668-674.
23. Explanation of parameters as defined in the heartmate II LVAS operating manual. http://www.Thoratec.Com/medical-professionals/resourcelibrary/ ifus-manuals/download/639. Accessed March 18, 2012.
24. Wever-Pinzon O, Stehlik J, Kfoury AG, Terrovitis JV, Diakos NA, Charitos C, Li DY, Drakos SG. Ventricular assist devices: pharmacological aspects of a mechanical therapy. Pharmacol Ther. 2012;134:189-199.
25. Adverse event definitions in the manual of operations version 2.3 for the interagency registry of mechanically assisted circulatory support (INTERMACS). http://www.Uab.Edu/ctsresearch/intermacs/manuals. Htm. Accessed March 18, 2012.
26. Kaplan EL, Meier P Nonparametric estimation from incomplete observations J Am Statist Assn. 1958;53:457-481.
27. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-170.
28. Cox DR. Regression models and life-tables. R Stat Soc Series B Stat Methodol. 1972;34:187-220.
29. Tarzia V, Dal Lin C, Bottio T, Benvenuti S, Chilovi F, Gerosa G. Occult gastrointestinal bleeding in patients with a left ventricular assist device axial flow pump: diagnostic tools and therapeutic algorithm. J Thorac Cardiovasc Surg. 2012;143:e28-e31.
30. Hayes HM, Dembo LG, Larbalestier R, O'Driscoll G. Management options to treat gastrointestinal bleeding in patients supported on rotary left ventricular assist devices: a single-center experience. Artif Organs. 2010;34:703-706.
31. Crow S, John R, Boyle A, Shumway S, Liao K, Colvin-Adams M, Toninato C, Missov E, Pritzker M, Martin C, Garry D, Thomas W, Joyce L. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg. 2009;137:208-215.
32. Stern DR, Kazam J, Edwards P, Maybaum S, Bello RA, D'Alessandro DA, Goldstein DJ. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. J Card Surg. 2010;25:352-356.
33. Geisen U, Heilmann C, Beyersdorf F, Benk C, Berchtold-Herz M, Schlensak C, Budde U, Zieger B. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg. 2008;33:679-684.
34. Crow S, Milano C, Joyce L, Chen D, Arepally G, Bowles D, Thomas W, Ortiz NV. Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients. ASAIO J. 2010;56:441-445.
35. Kawahito S, Nakata K, Nonaka K, Sato T, Yoshikawa M, Takano T, Maeda T, Linneweber J, Schulte-Eistrup S, Flowers D, Glueck J, Nosé Y. Analysis of the arterial blood pressure waveform using Fast Fourier Transform technique during left ventricular nonpulsatile assistance: in vitro study. Artif Organs. 2000;24:580-583.
36. Kawahito S, Takano T, Nakata K, Maeda T, Nonaka K, Linneweber J, Schulte-Eistrup S, Sato T, Mikami M, Glueck J, Nosé Y. Analysis of the arterial blood pressure waveform during left ventricular nonpulsatile assistance in animal models. Artif Organs. 2000;24:816-820.
37. Myers TJ, Bolmers M, Gregoric ID, Kar B, Frazier OH. Assessment of arterial blood pressure during support with an axial flow left ventricular assist device. J Heart Lung Transplant. 2009;28:423-427.
38. Schwartz J, Rozenfeld V, Stelian J, Leibovitz A, Rabinovitz H, Habot B. Bleeding angiodysplasia of stomach associated with severe ischemic congestive cardiomyopathy: a case history. Angiology. 1993;44:584-586.
39. Lenato GM, Suppressa P, Giordano P, Guanti G, Guastamacchia E, Triggiani V, Amati L, Resta F, Covelli V, Jirillo E, Sabbà C. Hereditary haemorrhagic telangiectasia: a rare disease as a model for the study of human atherosclerosis. Curr Pharm Des. 2007;13:3656-3664.
40. Souto JC, Almasy L, Muñiz-Diaz E, Soria JM, Borrell M, Bayén L, Mateo J, Madoz P, Stone W, Blangero J, Fontcuberta J. Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol. 2000;20:2024-2028.
41. Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, Yang S, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, Varrone J, Yusuf S. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation. 2011;123:2363-2372.
42. Winkelmayer WC, Levin R, Avorn J. Chronic kidney disease as a risk factor for bleeding complications after coronary artery bypass surgery. Am J Kidney Dis. 2003;41:84-89.